| 期 |
标题 |
文件 |
| 卷 2, 编号 1 (2020) |
Approaches to the assessment of quantitative composition of drugs based on natural peptides containing glycosaminoglycan-peptide complex |
(Rus)
|
|
Vengerovich N., Efimov N., Rogozhina N., Stepchenkov V.
|
| 卷 2, 编号 1 (2020) |
Evaluation of the 223Ra-dichloride biodistribution models for the assessment of the doses from internal exposure |
(Rus)
|
|
Vodovatov A., Chipiga L., Petrova A., Stanzhevsky A.
|
| 卷 2, 编号 1 (2020) |
Aspects of pesticide and agrochemical application in the field of beekeeping |
(Rus)
|
|
Paramonov S.
|
| 卷 2, 编号 1 (2020) |
Valery Galynkin: "a Scientist should also be a practitioner» |
(Rus)
|
|
Zvyagin Y.
|
| 卷 2, 编号 1 (2020) |
Moses Efimovich Bergolts: first rector of the revived institute |
(Rus)
|
|
Narkevich I., Stepanov S., Zvyagin Y., Vorobeva S., Perelygin V., Dobrova D.
|
| 卷 2, 编号 1 (2020) |
Modern polymers in prolonged release tablet technology |
(Rus)
|
|
Kotsur J., Flisyuk E.
|
| 卷 2, 编号 1 (2020) |
Morpholine derivatives as potential agents for neurological manifestations of nervous system diseases |
(Rus)
|
|
Prikhodko V., Sysoev Y., Okovityi S.
|
| 卷 2, 编号 1 (2020) |
Pathogenic substantiation of application of erythropoietin modified forms and peptide analogues as cytotprotectors |
(Rus)
|
|
Ivanov I., Nikiforov A., Vengerovich N., Perelygin V., Proshina Y.
|
| 卷 2, 编号 1 (2020) |
Processing and evaluation of qualitative data of the pharmaceutical market using economic and statistical methods |
(Rus)
|
|
Umarov S.
|
| 卷 2, 编号 1 (2020) |
From the editors |
(Rus)
|
|
Narkevich I.
|
| 卷 2, 编号 4 (2020) |
Approaches to assessing the sexual behavior of male rats in the study of the effects of compounds that have a stimulating effect on sexual function |
(Rus)
|
|
Subbotina S., Kryazhevskikh A., Kryazhevskikh A., Yudin M., Eletskaya E.
|
| 卷 3, 编号 1 (2021) |
The development of an algorithm for introduction of a new drug on the existing pharmaceutical production. Stage 2. Transfer of technologies |
(Rus)
|
|
Basevich A., Dzjuba A., Kaukhova I., Tretyakova A., Sakharov V.
|
| 卷 2, 编号 4 (2020) |
Multi-vector analysis of the market for drugs used to treat hepatitis C |
(Rus)
|
|
Narkevich I., Nemyatykh O., Siukaeva D., Tsitlionok E., Lisacenco V., Grinyuk A.
|
| 卷 2, 编号 4 (2020) |
The aspects that describe the pre-clinical studies of aceclofenac, as an instrument of registration of a generic drug |
(Rus)
|
|
Anisimova N., Selizarova N., Plisko G., Semivelichenko E., Napalkova S.
|
| 卷 2, 编号 4 (2020) |
Generalized data of criteria of risk factors for the use of the drug torasemide from the materials of its preclinical studies |
(Rus)
|
|
Anisimova N., Selizarova N., Plisko G., Semivelichenko E., Napalkova S.
|
| 卷 2, 编号 4 (2020) |
Identification of actoprotective compounds among Krebs cycle acid/aminoethanol derivatives |
(Rus)
|
|
Bolotova V., Shustov E., Okovityi S.
|
| 卷 2, 编号 4 (2020) |
The benefits or harms of systemic corticosteroids for community-acquired pneumonia in adults: аn overview of reviews |
(Rus)
|
|
Efimov N., Sayfullin R., Shunkov V.
|
| 卷 2, 编号 4 (2020) |
Modern aspects of myocardial infarction treatment in older patients |
(Eng)
|
|
Kozlov K., Bogomolov A., Lukianov N., Senkina E., Pukhalskaya A.
|
| 卷 2, 编号 4 (2020) |
Development of the design of the preclinical trials of radiopharmaceuticals for the radionuclide diagnostics and therapy based on the AMBA peptide |
(Rus)
|
|
Stanzhevsky A., Mosunov A., Chipiga L., Vodovatov A., Naurzbaeva L., Kushnarenko S., Lavreshov D., Petrova A.
|
| 卷 2, 编号 4 (2020) |
Search for the optimal mass profile of neuropeptides for the implementation of antihypoxic and activating actions |
(Rus)
|
|
Shustov E., Ivkin D., Ivkina A., Kim A., Lublin S., Nesterov M.
|
| 卷 2, 编号 4 (2020) |
Prevention and treatment of cancer using so-called medicinal mushrooms raw materials: Criticism, facts, and perspectives |
(Rus)
|
|
Zmitrovich I., Vlasenko V., Perelygin V., Figurin I.
|
| 卷 3, 编号 1 (2021) |
Dementia in elderly patients as a consequence of arterial hypertension: a literature review |
(Rus)
|
|
Mikhailov S., Kozlov K., Shishkevich A., Bessonov E., Lukjanov N., Pukhalskaya A.
|
| 卷 2, 编号 4 (2020) |
Antipsychotics: from first to third generation |
(Rus)
|
|
Petrova N., Sofronov A.
|
| 卷 2, 编号 4 (2020) |
From the editorial Board |
(Rus)
|
|
Perelygin V., Zvyagin Y.
|
| 卷 2, 编号 4 (2020) |
Adel Fedorovna Hammermann (1888–1978) |
(Rus)
|
|
Narkevich I., Luganin V., Bespalova N., Zvyagin Y., Perelygin V.
|
| 卷 2, 编号 4 (2020) |
Investigation of the antibacterial effectiveness of drinking water preparation using the “TYENT Water Ionizer” |
(Rus)
|
|
Paramonov S.
|
| 卷 2, 编号 4 (2020) |
“Young pharmacy-the potential of the future” 2020: result of conference |
(Rus)
|
|
Zagorulko E., Rozhkov G., Povydysh M.
|
| 卷 2, 编号 4 (2020) |
Ensuring energy efficiency at pharmaceutical enterprises in the paradigm of reducing the technogenic load on the environment |
(Rus)
|
|
Perelygin V., Sklyarova N., Miroshnichenko Y., Ivanov S., Sakharov V., Drachkova I., Zharikov M.
|
| 卷 2, 编号 4 (2020) |
Unique archive of medical history scientific materials are already available! |
|
|
扎里科夫 迈.
|
| 卷 3, 编号 1 (2021) |
Pyotr Ivanovich Astrakhantsev: the first post-war director of the Leningrad Institute of Pharmacy |
(Rus)
|
|
Narkevich I., Stepanov S., Volgusheva A., Zvyagin Y., Vorobeva S., Perelygin V.
|
| 卷 3, 编号 1 (2021) |
The role of scientists in the Department of Psychiatry at the S.M. Kirov Military Medical Academy in the development of domestic narcology and pharmacological methods of treating this pathology |
(Rus)
|
|
Tchudinovskih A., Zvyagin Y.
|
| 卷 3, 编号 1 (2021) |
Docking of highly selective 5-HT2A/C receptor peptide ligands with antipsychotic activity |
(Eng)
|
|
Orlova A., Sventitskaya A., Vengerovich N., Nikiforov A., Ivanov I., Proshina Y.
|
| 卷 3, 编号 1 (2021) |
Medical gas supply systems in the context of a pandemic |
(Rus)
|
|
Kravchenko A.
|
| 卷 3, 编号 1 (2021) |
Comparative bioelectronic diagnostics of the ecological state of contaminated water areas (on the example of some ducts of the Volga River Delta) |
(Rus)
|
|
Kholodkevich S., Motruk M., Lyubimtsev V., Susloparova O.
|
| 卷 3, 编号 1 (2021) |
From the editor |
(Rus)
|
|
Narkevich I., Perelygin V.
|
| 卷 3, 编号 1 (2021) |
Comparison of the therapeutic effectiveness of the drug Mucosat based on glycosaminoglycans in oral and parenteral dosage forms in the treatment of osteoarthritis |
(Rus)
|
|
Peshekhonova L., Peshekhonov D., Pyatibrat A., Vengerovich N.
|
| 卷 3, 编号 1 (2021) |
The significance of the original characteristics of the active substance of injectable chondroitin sulfate preparations for intramuscular injections in the evidence-based medicine |
(Rus)
|
|
Napalkova S., Okovityi S., Ivkin D., Pyatibrat A.
|
| 卷 3, 编号 2 (2021) |
Battery of tests for studying the adaptogenic effects of biologically active substances in preclinical trials |
(Rus)
|
|
Shustov E., Okovityi S., Bolotova V., Kim A.
|
| 卷 3, 编号 2 (2021) |
Tumor growth – a modern view of pathogenesis and pharmacotherapy (lecture) |
(Rus)
|
|
Tyukavin A., Suchkov S.
|
| 卷 3, 编号 2 (2021) |
Regulatory framework and prospects for the implementation of the Electronic Prescription System in the Russian Federation |
(Rus)
|
|
Zolotareva N., Pokhvalenko E.
|
| 卷 3, 编号 2 (2021) |
Some aspects of pesticide contamination of medicinal plants |
(Rus)
|
|
Paramonov S.
|
| 卷 3, 编号 2 (2021) |
Socio-biological factors of increased morbidity risk in participants of educational process in higher education institutions related to the global epidemiological situation in 2020-2021 |
(Rus)
|
|
Perelygin V., Paramonov S., Sklyarova N., 扎里科夫 迈., Sklyarova L.
|
| 卷 3, 编号 2 (2021) |
Director Nikolai Vasilyevich Koshkin: the Institute has become Chemical and Pharmaceutical again |
(Rus)
|
|
Narkevich I., Stepanov S., Volgusheva A., Zvyagin Y., Vorobeva S., Perelygin V.
|
| 卷 3, 编号 2 (2021) |
State of the Russian Oncology Service: malignant neoplasms of the tongue C01, 02 (age-specific incidence rate, localization and histological structure) Part 1 |
(Eng)
|
|
Merabishvili V., Merabishvili E., Shcherbakov A., Vasilyev A., Barsukov A., Krotov N.
|
| 卷 3, 编号 2 (2021) |
State of the Russian Oncology Service: malignant neoplasms of the tongue C01, 02 (mortality rate and median survival of patients, taking into account the stage of the disease and histological structure of the tumor) Part 2 |
(Eng)
|
|
Merabishvili V.M., Merabishvili E., Scherbakov A., Vasilyev A., Krotov N., Barsukov A.
|
| 卷 3, 编号 2 (2021) |
Foreign experience in veterinaryapplication of scintigraphy |
(Rus)
|
|
Lunegova I., Tyts V., Lunegov A.
|
| 卷 3, 编号 2 (2021) |
Steroid hormones and their metabolites in water of centralized drinking water supply systems as ecopolutants |
(Rus)
|
|
Vengerovich N., Perelygin V.
|
| 卷 3, 编号 2 (2021) |
Personal protective equipment waste potentially infected with SARS-CoV-2 – a new global challenge for biological safety |
(Rus)
|
|
Donchenko V., Sakharov V., Sakharova O.
|
| 卷 3, 编号 1S (2021): Supplement |
From the editor |
(Rus)
|
|
Perelygin V.
|
| 卷 3, 编号 1S (2021): Supplement |
Opening remarks |
(Rus)
|
|
Flisyuk E.
|
| 卷 3, 编号 1S (2021): Supplement |
Opening remarks |
(Rus)
|
|
Donchenko V.
|
| 卷 3, 编号 1S (2021): Supplement |
Approaches to training and supply of qualified personnel for radiation medicine facilities |
(Rus)
|
|
Perelygin V., Sklyarova N., Sakharov V., Zharikov m.
|
| 卷 3, 编号 1S (2021): Supplement |
Methods of biological waste management generated by patients |
(Rus)
|
|
Vodovatov A.
|
| 卷 3, 编号 1S (2021): Supplement |
Review of the practice-based experience of radiopharmaceutical waste management in healthcare institutions |
(Rus)
|
|
Donchenko V., Sakharov V., Sakharova O.
|
| 卷 3, 编号 1S (2021): Supplement |
Epidemiology and survival rates of patients with malignant tumors in the Russian Federation |
(Rus)
|
|
Merabishvili V.
|
| 卷 3, 编号 1S (2021): Supplement |
Prospective directions and problems of ensuring Radiation Safety in Radiation Medicine |
(Rus)
|
|
Chipiga L.
|
| 卷 3, 编号 1S (2021): Supplement |
Radiation Medicine: Past and Present |
(Rus)
|
|
Soukhov V.
|
| 卷 3, 编号 1S (2021): Supplement |
Practical experience in reactor and cyclotron radiopharmaceuticals production at the V.G. Khlopin Radium Institute |
(Rus)
|
|
Kudellin B.
|
| 卷 3, 编号 1S (2021): Supplement |
Quality control management in the production of radiopharmaceuticals at the A.M. Granov Russian Scientific Centre for Radiology and Surgical Technologies |
(Rus)
|
|
Nepochatov I.
|
| 卷 3, 编号 1S (2021): Supplement |
Science research experience in the use of radiopharmaceuticals at the N.N. Petrov NMRC of Oncology |
(Rus)
|
|
Krzhivitsky P.
|
| 卷 3, 编号 1S (2021): Supplement |
FATTY LIVER DYSTROPHY MODELING BY USING STRONTIUM SULFATE |
(Rus)
|
|
Ponamarev V., Lunegov A., Lunegova I., Baryshev V., Zenkov K.
|
| 卷 3, 编号 1S (2021): Supplement |
PRELIMINARY RISK ANALYSIS METHOD FOR POTENTIAL CAUSES OF MEDICAL DEVICE FAILURE WITH THE USE OF DEDUCTIVE LOGIC IN CASE OF A MAN-MADE EMERGENCY SITUATION |
(Rus)
|
|
Babkin I.
|
| 卷 3, 编号 1S (2021): Supplement |
Development of the environmentally safe habitat based on local life-support systems |
(Rus)
|
|
Leschinsky V.
|
| 卷 3, 编号 1S (2021): Supplement |
Ecotecture of the extreme Arctic environment |
(Rus)
|
|
Troshin V., Zvyagin Y.
|
| 卷 3, 编号 1S (2021): Supplement |
ACUTE RADIATION INJURY: COURSE AND OUTCOME IN A RAT MODEL WITH THE IODINE AND SELENIUM PREPARATIONS ADMINISTRATION |
(Rus)
|
|
Vasil'ev R., Troshin E., Brevnova S., Yugatova N.
|
| 卷 3, 编号 1S (2021): Supplement |
Greeting |
(Rus)
|
|
Narkevich I.
|
| 卷 3, 编号 1S (2021): Supplement |
Greeting |
(Rus)
|
|
Belyaev A.
|
| 卷 3, 编号 1S (2021): Supplement |
Greeting |
(Rus)
|
|
Mkrtchyan M.
|
| 卷 3, 编号 1S (2021): Supplement |
Greeting |
(Rus)
|
|
Archipenko L.
|
| 卷 3, 编号 1S (2021): Supplement |
Application of the Environmental Safety terms and definitions in pharmaceutical organizations |
(Rus)
|
|
Shmarova A.
|
| 卷 3, 编号 1S (2021): Supplement |
The decision of the scientific and practical conference " Environmental Protection. Assessment of environmental risks in the handling of radiopharmaceutical drug waste" |
(Rus)
|
|
Flisyuk E.
|
| 卷 3, 编号 2 (2021) |
Effect of organophosphorus compounds on the external respiratory functionin rats during intratracheal andintraperitonealadministration |
(Rus)
|
|
Kryazhevskikh A., Kryazhevskikh A., Subbotina S., Sklyarova N.
|
| 卷 3, 编号 3 (2021) |
State of the Russian Oncology Service: esophageal cancer. Population-based study at the federal district level. Part I. Morbidity and mortality rates, accuracy index, annual mortality |
(Eng)
|
|
Merabishvili V.
|
| 卷 3, 编号 3 (2021) |
State of the Russian Oncology Service: esophageal cancer. Population-based study at the federal district level. Part II. Median survival, observed and relative survival of patients considering disease stage and histological structure of tumors |
(Eng)
|
|
Merabishvili V.
|
| 卷 3, 编号 2 (2021) |
From the editor |
(Rus)
|
|
Perelygin V.
|
| 卷 3, 编号 3 (2021) |
Obtaining and research of pharmaceutical properties of antiemetics in a form of powder for inhalation |
(Eng)
|
|
Ivanov I., Pechurina T., Vengerovich N., Yudin M., Nikiforov A., Raguzin E., Kuzmich V., Proshina Y.
|
| 卷 3, 编号 3 (2021) |
Investigation of the properties and activity of DfCas9 and DsCas9 nucleases in eucaryotic cells |
(Rus)
|
|
Vlasova Y., Madera D., Gershovich P.
|
| 卷 3, 编号 3 (2021) |
Preliminary evaluation of patient radiation doses during radionuclide diagnostic with monoclonal antibodies labeled with 89Zr |
(Rus)
|
|
Chipiga L., Petrova A., Mosunov A., Naurzbaeva L., Kushnarenko S., Lavreshov D., Vodovatov A., Stanzhevsky A., Maistrenko D.
|
| 卷 3, 编号 2 (2021) |
CORRIGENDUM TO: [Pharmacy Formulas. - 2021. - Vol. 3. - N. 1. - P. 66-75. doi: 10.17816/phf60598] |
(Rus)
|
|
Peshekhonova L., Peshekhonov D., Pyatibrat A., Vengerovich N.
|
| 卷 3, 编号 3 (2021) |
Interactomics and personalized pharmacotherapy – present and looking to the future |
(Rus)
|
|
Tyukavin A., Studneva M., Suchkov S.
|
| 卷 3, 编号 3 (2021) |
Viktor Nikolaevich Ivanov: the Director of the Leningrad Institute of Chemistry and Pharmacy in the 1950s |
(Rus)
|
|
Narkevich I., Stepanov S., Zvyagin Y., Vorobeva S., Perelygin V.
|
| 卷 3, 编号 3 (2021) |
Development of professional standards in the area of medical and biological waste management for workers of 3-4 skill levels |
(Rus)
|
|
Perelygin V., Sklyarova N., Vasiliev V., Zharikov M., Sklyarova L.
|
| 卷 3, 编号 3 (2021) |
The role of society in public administration in the field of environmental protection. Global problems of our time. Part I |
(Rus)
|
|
Sapunov V., Zharikov M.
|
| 卷 3, 编号 4 (2021) |
Biodizine as a civilizational challenge of modern pharmaceuticals |
(Rus)
|
|
Tyukavin A., Arseniev N., Studneva M., Medvedeva V., Suchkov S.
|
| 卷 3, 编号 4 (2021) |
State of the Russian Oncology Service: lip cancer. Population-based study at the federal district level. Part I. Incidence rate, annual mortality rate, localization and histological structure |
(Rus)
|
|
Merabishvili V., Vasilyev A., Merabishvili E., Barsukov A.
|
| 卷 3, 编号 4 (2021) |
State of the Russian Oncology Service: lip cancer. Population-based study at the federal district level. Part II. Survival of patients, median of survival, survival of patients taking into account the localization, histological
structure and disease stage |
(Rus)
|
|
Merabishvili V., Vasilyev A., Merabishvili E., Barsukov A.
|
| 卷 3, 编号 4 (2021) |
Applications of chitosan as a polymer carrier for increasing the drugs’ bioavailability |
(Rus)
|
|
Ustinova T., Vengerovich N., Glinko D.
|
| 卷 3, 编号 3 (2021) |
From the editor |
(Rus)
|
|
Efimov N.
|
| 卷 3, 编号 4 (2021) |
Supergroups of eukaryotes through a biotechnologist’s look. The system of eukaryotes and the need for a taxonomic/biotechnological interface |
(Rus)
|
|
Zmitrovich I., Perelygin V., Zharikov M.
|
| 卷 3, 编号 4 (2021) |
Information technologies in the analysis of pharmaceutical personnel security |
(Rus)
|
|
Klishchenko M., Kuznetsov D.
|
| 卷 3, 编号 4 (2021) |
The use of Mexidol-Vet® against the background of ultraviolet and gamma irradiation in rats |
(Rus)
|
|
Troshin E., Yugatova N., Vasil'ev R.
|
| 卷 3, 编号 4 (2021) |
Problems of solid radioactive waste management on the example of the radioactive isotope 14C |
(Rus)
|
|
Perelygin V., Kotenko P., Podboronova A., Zharikov M., Sklyarova L.
|
| 卷 3, 编号 4 (2021) |
Ecotoxicological assessment of waste and soil cover of anthropogenic polluted territories using biotest systems |
(Rus)
|
|
Bardina T., Podboronova A., Sklyarova L.
|
| 卷 3, 编号 4 (2021) |
Current issues in clinical trials of radiopharmaceutical drugs at the present stage of nuclear medicine development |
(Rus)
|
|
Efimov N., Lebedinets A.
|
| 卷 3, 编号 4 (2021) |
The formation of the SPSUVM Department of Pharmacology and Toxicology |
(Rus)
|
|
Lunegov A.
|
| 卷 4, 编号 1 (2022) |
Prevalence and survival of patients with malignant tumors of the thymus gland (C37) (population study at the federal district level) |
(Rus)
|
|
Merabishvili V.
|
| 卷 4, 编号 1 (2022) |
Environmental risks of the tetracycline micro pollution |
(Rus)
|
|
Paramonov S., Zelikova D., Sklyarova L., Alkhutova I.
|
| 卷 3, 编号 4 (2021) |
Development of the emulsion composition and technology based on iron oleate micelles |
(Rus)
|
|
Trofimov M., Goncharenko A., Plisko G., Semivelichenko E., Muslimov A., Ivkina A.
|
| 卷 3, 编号 4 (2021) |
A roadmap for the development of “Training system of specialists for nuclear medicine facilities at the Saint Petersburg State Chemical and Pharmaceutical University” |
(Rus)
|
|
Perelygin V., Sklyarova N.
|
| 卷 3, 编号 4 (2021) |
FROM THE EDITOR |
(Rus)
|
|
Narkevich I.
|
| 卷 3, 编号 4 (2021) |
Current aspects of the preclinical studies development for the pharmaceutical industry of the Eurasian Economic Union |
(Rus)
|
|
Ivkin D.
|
| 卷 3, 编号 4 (2021) |
Arctic as a radiation zone: problems and solutions |
(Rus)
|
|
Troshin V.
|
| 卷 4, 编号 1 (2022) |
Pharmacological potential of ligands to receptors of RF-amide neuropeptide system |
(Rus)
|
|
Yakovlev O., Vengerovich N., Nikiforov A., Vakhviyaynen M.
|
| 卷 4, 编号 1 (2022) |
Biotesting methods for the detection of drugs in the aquatic environment |
(Rus)
|
|
Kryazhevskikh A., Bardina V., Sklyarova N.
|
| 卷 4, 编号 1 (2022) |
Approaches to radiation situation assessment and prediction in the Baltic Sea |
(Rus)
|
|
Savkina E., Sklyarova L., Podboronova A., Zharikov M., Perelygin I.
|
| 卷 4, 编号 1 (2022) |
Microbiological analysis of the quality of tap and filtered water in St. Petersburg, taking into account modern requirements |
(Rus)
|
|
Bogdanova O., Chernykh T.
|
| 卷 4, 编号 1 (2022) |
Historical aspects of legal regulation of pharmacy as structural units of large organizations |
(Rus)
|
|
Perelygin V., Pokhvalenko E., Zolotareva N., Zharikov M.
|
| 卷 4, 编号 1 (2022) |
Assessment of human health and modern laboratory tests |
(Rus)
|
|
Dorofeykov V.
|
| 卷 4, 编号 1 (2022) |
Igor Narkevich. To be continued… |
(Rus)
|
|
Volgusheva A., Vorobeva S., Perelygin V., Zakonchinskaya N.
|
| 卷 4, 编号 3 (2022) |
Phyto-stimulating activity of the paracetamol-containing waste biodestruction product |
(Rus)
|
|
Vikhareva E., Mishenina I., Agafontseva A., Rychkova M.
|
| 卷 4, 编号 3 (2022) |
Morbidity, mortality, reliability of accounting, survival of patients with malignant neoplasms (ZNO) in Russia. The impact of the SARS-CoV-2-betacoronavirus coronavirus epidemic (population study at the federal district level) |
(Rus)
|
|
Merabishvili V.
|
| 卷 4, 编号 3 (2022) |
Aspects of the problem of clinical trials of modern targeted radiopharmaceuticals |
(Rus)
|
|
Rabinovich E., Savchenko A., Sukhov V., Perelygin V.
|
| 卷 4, 编号 3 (2022) |
Microbiological analysis of spring water in the Leningrad region |
(Rus)
|
|
Bogdanova O., Chernykh T.
|
| 卷 4, 编号 3 (2022) |
Water and its importance for human life and health |
(Rus)
|
|
Lunegova I., Tyts V., Lopatin S.
|
| 卷 4, 编号 3 (2022) |
Latest technologies of diagnostics and treatment of diseases of the musculoskeletal system |
(Rus)
|
|
Tyukavin A., Solomennikov A., Umarov S.
|
| 卷 4, 编号 3 (2022) |
Molecular mechanisms of transport of substances across the blood-brain barrie as targets for pharmacological action. Part 2. Modern methods of delivery of pharmacological agents to the central nervous system |
(Rus)
|
|
Litvinova M., Trofimov A., Shabanov P., Lebedev A., Bychkov E., Arseniev N., Tyukavin A.
|
| 卷 4, 编号 3 (2022) |
Joseph Afroimovich Sterin |
(Rus)
|
|
Napalkova S., Okovityi S., Veselova O., Perelygin V., Dyomina K.
|
| 卷 4, 编号 4 (2022) |
On the conceptual project of an environmental management system at a pharmaceutical biotechnology enterprise |
(Rus)
|
|
Perelygin V., Sakharov V.
|
| 卷 4, 编号 4 (2022) |
Molecular mechanisms of cell functioning in norm and pathology |
(Rus)
|
|
Tyukavin A., Suchkov S.
|
| 卷 4, 编号 4 (2022) |
Modern technologies for the diagnostics and treatment of hearing diseases (Lecture for pharmacists - in the field of training 38.03.07 “Commodity science”) |
(Rus)
|
|
Tyukavin A., Solomennikov A., Umarov S.
|
| 卷 4, 编号 4 (2022) |
To the 80th anniversary of Professor Thomas Cavalier-Smith (1942–2021) |
(Rus)
|
|
Zmitrovich I., Perelygin V., Zharikov M.
|
| 卷 4, 编号 2 (2022) |
Evaluation of the effect of Cassia fistula L. extracts on the muscle contraction intensity using an ex vivo model |
(Eng)
(Rus)
|
|
Ranadive K., Jagtap N., Jagtap P., Perelygin V., Zharikov M., Zmitrovich I., Sanjay G.
|
| 卷 4, 编号 2 (2022) |
Smoking and lung cancer (clinical and epidemiological study) |
(Rus)
|
|
Yurkova Y., Merabishvili V.
|
| 卷 4, 编号 2 (2022) |
Molecular mechanisms of molecular transfer across the blood-brain barrier as a target for pharmacological action. Part 1. Structure, function and pathology of the BBB |
(Rus)
|
|
Trofimov A., Litvinova M., Schwarz A., Kosheverova V., Lebedev A., Arseniev N., Tyukavin A.
|
| 卷 4, 编号 2 (2022) |
The life path of A. M. Khaletsky |
(Rus)
|
|
Narkevich I., Volgusheva A., Vorobeva S., Perelygin V., Dyomina K.
|
| 卷 5, 编号 2 (2023) |
State of oncological care in Russia: age and cancer. Features of the localization structure, quality of recording, and survival of young adults with malignant neoplasms (clinical-population study). Part 2 |
(Rus)
|
|
Merabishvili V., Shakhzadova A., Kulyova S., Perelygin V.
|
| 卷 5, 编号 2 (2023) |
State of cancer care in Russia: Age and cancer. Features of localization structure, quality of recording, and survival of middle-aged patients with CNS tumors (a clinical-population study). Part 3 |
(Rus)
|
|
Merabishvili V., Shakhzadova A., Perelygin V.
|
| 卷 5, 编号 2 (2023) |
Detection of the pesticide glyphosate in feed and ways to reduce its content for poultry |
(Rus)
|
|
Melikidi V., Tyurina T., Laptev G.
|
| 卷 5, 编号 2 (2023) |
Leonid Arkadyevich Loshakov: «Knowledge is priceless. Verified» |
(Rus)
|
|
Zolotaryva N., Pokhvalenko E.
|
| 卷 5, 编号 1 (2023) |
Candidiasis: the problem of finding new etiotropic drugs among organic synthesis products |
(Rus)
|
|
Novikova V., Gein V., Bobrovskaya O., Pulina N., Igidov N., Rudakova I.
|
| 卷 5, 编号 1 (2023) |
The state of cancer care in Russia: age and cancer. Features of the localization structure of the quality of accounting and survival of patients with malignant tumors among the child population, adolescents and young adults in Russia (clinical and population study). Part 1 |
(Rus)
|
|
Merabishvili V., Shakhzadova A., Kulyova S., Perelygin V.
|
| 卷 5, 编号 1 (2023) |
Modern technologies for diagnosis and treatment of eye diseases |
(Rus)
|
|
Tyukavin A., Solomennikov A., Umarov S.
|
| 卷 5, 编号 1 (2023) |
Alexander Georgievich Egorov was the rector of Leningrad Chemical-Pharmaceutical Institute from 1958 to 1972 |
(Rus)
|
|
Narkevich I., Vorobeva S., Volgusheva A., Perelygin V.
|
| 卷 5, 编号 3 (2023) |
The state of cancer care in Russia: age and cancer. Features of localization structure, quality of accounting and survival of elderly patients with ZNO (population study). Part 4 |
(Rus)
|
|
Merabishvili V., Shakhzadova A., Perelygin V.
|
| 卷 5, 编号 3 (2023) |
Domain Archaea – system overview, metabolism, biotechnological potential |
(Rus)
|
|
Zmitrovich I., Perelygin V., Zharikov M.
|
| 卷 5, 编号 3 (2023) |
About the first head of the Department of Economics and Management, Professor Lin Alexander Alekseevich |
(Rus)
|
|
Narkevich I., Orlov A., Trofimova E., Vorobieva S.
|
| 卷 5, 编号 4 (2023) |
The state of cancer care in Russia: age and cancer. Features of the localization structure, quality of accounting and survival of patients with malignant neoplasms of senile age and centenarians (population study). Part 5 |
(Rus)
|
|
Merabishvili V., Shakhzadova A., Perelygin V.
|
| 卷 5, 编号 4 (2023) |
Glucans and heteroglycans of fungi and their potential in cancer immunotherapy |
(Rus)
|
|
Zmitrovich I., Perelygin V., Zharikov M.
|
| 卷 5, 编号 4 (2023) |
The influence of short-term heating on the activity of amylolytic enzymes in honey |
(Rus)
|
|
Solovyova V., Tikhomirov V., Filatova K., Paramonov S.
|
| 卷 5, 编号 4 (2023) |
Life path of Leonid Vasilyevich Dmitrenko |
(Rus)
|
|
Glazova N., Berdnikova Y.
|
| 卷 5, 编号 4 (2023) |
Half a Century in Service: Professor Leonid Gerasimovich Marchenko (1941–2019) |
(Rus)
|
|
Flisyuk E., Marchenko A.
|
| 卷 6, 编号 1 (2024) |
The State of Oncology Care in Russia: Localization Structure Features, Quality of Recording, and Survival of Cancer Patients in the Major Age Groups of the Population (population study). Part 6 |
(Rus)
|
|
Merabishvili V., Shakhzadova A., Belyaev A., Kuleva S., Perelygin V.
|
| 卷 6, 编号 1 (2024) |
The state of cancer care in Russia: liver cancer – (C22). Age-related characteristics of morbidity and mortality, quality of registration, effectiveness of patient treatment. (clinical population study). Part 1 |
(Rus)
|
|
Merabishvili V., Bagnenko S., Balakhnin P., Busko E.
|
| 卷 6, 编号 1 (2024) |
The study of indicators of authenticity and goodness of flowers of narrow-leaved lavender (Lavandula angustifolia L.) |
(Rus)
|
|
Whaley A., Whaley A., Zhokhova E., Suloev I., Abdumazhidova I., Farmanova N., Yakovlev G.
|
| 卷 6, 编号 1 (2024) |
Organization of storage of various groups of medicines in pharmacy organizations |
(Rus)
|
|
Pokhvalenko E., Zolotareva N.
|
| 卷 6, 编号 1 (2024) |
A scientist and a world-class personality: Nikolai Petrovich Elinov (1928–2017) |
(Rus)
|
|
Narkevich I., Vorobieva S., Volgusheva A., Perelygin V., Pleshakov I., Sobolnikova E., Ananieva E., Сhernych T.
|
| 卷 6, 编号 1 (2024) |
Life Path of Professor Elena Pavlovna Yakovleva (1938–2023) |
(Rus)
|
|
Kolodyaznaya V., Topkova O., Kotova N.
|
| 卷 6, 编号 2 (2024) |
Aspects of microbiological monitoring of the production environment in pharmaceutical and biotechnological manufacturing |
(Rus)
|
|
Bogdanova O., Chernykh T., Bukovskaya J.
|
| 卷 6, 编号 2 (2024) |
The state of oncological care in Russia: liver cancer (C22). Age-specific characteristics of observed and relative one-year and five-year survival rates of patients (clinical-population study). Part 2 |
(Rus)
|
|
Merabishvili V., Bagnenko S., Balakhnin P., Busko E.
|
| 卷 6, 编号 2 (2024) |
Chitin/chitosan: bioresources, applications field, production technologies |
(Rus)
|
|
Perelygin V., Nekrasova T., Zharikov M., Werner A., Zmitrovich I.
|
| 1 - 150 的 229 信息 |
1 2 > >> |
